Robin Robinson
Vorstandsvorsitzender bei Esperovax, Inc.
Profil
Robin A.
Robinson is currently the President & Chief Executive Officer at Esperovax, Inc. Prior to this, he was the Chief Scientific Officer at RenovaCare, Inc. He has also served as the Director of Biomedical Advanced Research & Development Authority from 2008 to 2016.
Earlier in his career, he worked as the Vaccines Director at Novavax, Inc. from 1995 to 2004.
Additionally, he held the position of Assistant Professor at The University of Texas Southwestern Medical Center.
Aktive Positionen von Robin Robinson
Unternehmen | Position | Beginn |
---|---|---|
Esperovax, Inc.
Esperovax, Inc. Pharmaceuticals: MajorHealth Technology Esperovax, Inc. develops capsule vaccines. The company is based in Plymouth, MI. The company was founded by David O'Hagan, Roger S. Newton, Savita Nikam. Robin A. Robinson has been the CEO of the company since 2023. | Vorstandsvorsitzender | 01.05.2023 |
Ehemalige bekannte Positionen von Robin Robinson
Unternehmen | Position | Ende |
---|---|---|
RENOVACARE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2023 |
Biomedical Advanced Research & Development Authority | Direktor/Vorstandsmitglied | 01.01.2016 |
NOVAVAX, INC. | Corporate Officer/Principal | 01.01.2004 |
The University of Texas Southwestern Medical Center | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NOVAVAX, INC. | Health Technology |
RENOVACARE, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Biomedical Advanced Research & Development Authority | |
Esperovax, Inc.
Esperovax, Inc. Pharmaceuticals: MajorHealth Technology Esperovax, Inc. develops capsule vaccines. The company is based in Plymouth, MI. The company was founded by David O'Hagan, Roger S. Newton, Savita Nikam. Robin A. Robinson has been the CEO of the company since 2023. | Health Technology |